JPS6155946B2 - - Google Patents
Info
- Publication number
- JPS6155946B2 JPS6155946B2 JP12656878A JP12656878A JPS6155946B2 JP S6155946 B2 JPS6155946 B2 JP S6155946B2 JP 12656878 A JP12656878 A JP 12656878A JP 12656878 A JP12656878 A JP 12656878A JP S6155946 B2 JPS6155946 B2 JP S6155946B2
- Authority
- JP
- Japan
- Prior art keywords
- formaldehyde
- nad
- enzyme
- addition
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 40
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- 102100039702 Alcohol dehydrogenase class-3 Human genes 0.000 claims description 25
- 108010051015 glutathione-independent formaldehyde dehydrogenase Proteins 0.000 claims description 25
- 229950006238 nadide Drugs 0.000 claims description 22
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- 108010024636 Glutathione Proteins 0.000 claims description 13
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 13
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 11
- AIJULSRZWUXGPQ-UHFFFAOYSA-N Methylglyoxal Chemical compound CC(=O)C=O AIJULSRZWUXGPQ-UHFFFAOYSA-N 0.000 claims description 8
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 claims description 8
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000758 substrate Substances 0.000 claims description 8
- 235000019253 formic acid Nutrition 0.000 claims description 7
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 7
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 7
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 4
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- 229940015043 glyoxal Drugs 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- 150000001299 aldehydes Chemical class 0.000 claims description 3
- 150000001412 amines Chemical class 0.000 claims description 3
- 125000000129 anionic group Chemical group 0.000 claims description 3
- 239000003945 anionic surfactant Substances 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 239000003093 cationic surfactant Substances 0.000 claims description 3
- 238000002523 gelfiltration Methods 0.000 claims description 3
- 239000002736 nonionic surfactant Substances 0.000 claims description 3
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 claims description 2
- 239000002280 amphoteric surfactant Substances 0.000 claims description 2
- 125000002091 cationic group Chemical group 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 description 31
- 108090000790 Enzymes Proteins 0.000 description 31
- 239000000243 solution Substances 0.000 description 14
- 239000000370 acceptor Substances 0.000 description 11
- 230000009471 action Effects 0.000 description 10
- 239000002609 medium Substances 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 7
- FBWADIKARMIWNM-UHFFFAOYSA-N N-3,5-dichloro-4-hydroxyphenyl-1,4-benzoquinone imine Chemical compound C1=C(Cl)C(O)=C(Cl)C=C1N=C1C=CC(=O)C=C1 FBWADIKARMIWNM-UHFFFAOYSA-N 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 239000008098 formaldehyde solution Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000011009 potassium phosphates Nutrition 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000011033 desalting Methods 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- -1 methanol and ethanol Chemical class 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 241000590020 Achromobacter Species 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 108010092464 Urate Oxidase Proteins 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- SXKNCCSPZDCRFD-UHFFFAOYSA-N betaine aldehyde Chemical compound C[N+](C)(C)CC=O SXKNCCSPZDCRFD-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229940111685 dibasic potassium phosphate Drugs 0.000 description 1
- 108700003601 dimethylglycine Proteins 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Description
本発明は新規なホルムアルデヒドデヒドロゲナ
ーゼおよびその製法に関する。
従来から知られているホルムアルデヒドデヒド
ロゲナーゼは酵母やウシ肝臓の生産する酵母とし
てニコチンアミドアデニンジヌクレオチド(以下
NADと略する)と、還元型グルタチオンの存在
下でのみ酵素作用を生ずる(酵素ハンドブツク、
朝倉書店刊、第97頁1977年参照)。またNADおよ
び/または還元型グルタチンの添加は要しない
が、ジクロロフエノールインドフエノール(以下
DCPIPと略する)の添加を要するホルムアルデ
ヒドデヒドロゲナーゼ(Antonie van Leeuwenh
―ock第41巻第89〜95頁1975年参照)、更には
NADおよび還元型グルタチオンの添加は要しな
いが、プテリジンまたはフエナジンメトサルフエ
ートの添加を要し、且つメタノールに対しても酸
化作用を有するホルムアルデヒドデヒドロゲナー
ゼが知られている。(Agr.Biol.Chem.第41巻第
467頁、1977年参照)。
またシユードモナス属に属する微生物がNAD
を電子受容体とし、活性発現に還元型グルタチオ
ンの添加を要しないホルムアルデヒドデヒドロゲ
ナーゼを生産する能力を有することが知られてい
る(Biochem.J.第116巻第357〜365頁1970年参
照)。
本発明者らは上記ホルムアルデヒドデヒドロゲ
ナーゼとは作用機作が全く異なり、NADのみを
電子受容体としてホルムアルデヒド、アセトアル
デヒド、プロピオンアルデヒド、メチルグリオキ
ザル、グリオキザルに作用するが、炭素数4以上
のアルデヒド類、アルコール類としてメタノー
ル、エタノール、プロパノール、エチレングリコ
ール、グリセロール、脂肪酸およびアミ類には作
用せず(基質濃度50mM)、また活性発現に還元
型グルタチオンの添加を要しない新規なホルムア
ルデヒドデヒドロゲナーゼを見出し、本発明に到
達した。
すなわち本発明は(1)少なくとも下記性質〜
を有してなる新規なホルムアルデヒドデヒドロゲ
ナーゼである。
HCHO+NAD+H2O→HCOOH+NADH2
上記のごとく、ニコチンアミドアデニンジヌ
クレオチドを介してホルムアルデヒドを酸化し
て蟻酸を生成し、逆の作用を有しない。
ニコチンアミドアデニンジヌクレオチドのみ
を電子受容体とする。ニコチンアミドアデニン
ジヌクレオチドホスフエート等の他の電子受容
体を利用しない。
活性発現に還元型グルタチオンの添加を要し
ない。
ホルムアルデヒドに対するKm値が8×10-5M
(PH7.5)であり、NADに対するKm値が12×
10-5M(PH7.5)である。
ホルムアルデヒドの他にアセトアルデヒド、
プロピオンアルデヒド、メチルグリオキザル、
グリオキザルにも作用するが、炭素数4以上の
アルデヒド類、アルコール類としてメタノー
ル、エタノール、プロパノール、エチレングリ
コール、グリセロール、脂肪酸およびアミン類
には作用しない(基質濃度50mM)。
分子量が150000±1000であり、等電点がPI=
5.2±0.1であり、至適PHが7.0〜8.0である。
非イオン系界面活性剤に対して安定である
が、アニオン系、カチオン系及び両性界面活性
剤に対して影響を受ける。
本発明のホルムアルデヒドデヒドロゲナーゼは
還元型グルタチオンの添加を要しない点におい
て、従来知られているホルムアルデヒドデヒドロ
ゲナーゼ(酵素ハンドブツク、朝倉書店刊、第97
頁1977年参照)とは相違する。また、DCPIPの
添加を要しない点において、従来のホルムアルデ
ヒドデヒドロゲナーゼ(Antonie van Leeuwenh
―ock第41巻第89〜95頁、1975年参照)とも相違
する。さらに、メタノールに対して酸化作用を有
しない点において、従来のホルムアルデヒドデヒ
ドロゲナーゼ(Agr.Biol.Chem.第41巻第467頁、
1977年参照)とも相違し、かつ、メチルアミン、
ジメチルアミン、トリメチルアミン等のアミン類
に対して酸化作用を有しない点において、従来の
ホルムアルデヒドデヒドロゲナーゼ(Biochem.J.
第116巻第357〜865頁、1970年参照)とも相違す
る。
次に本発明の新規なホルムアルデヒドデヒドロ
ゲナーゼについて詳述する。
(1) 作用
下記のごとく、NADを介してホルムアルデヒ
ドを酸化して蟻酸を生成し、逆の作用を有しな
い。
HCHO+NAD+H2O→HCOOH+NADH2
電子受容体としてNADのみを利用し、ニコチ
ンアミドアデニンジヌクレオチドホスフエート
(NADP)、ジクロロフエノールインドフエノール
(DCPIP)、プテリジン、フエナジンメトサルフ
エート(PMS)などの他の電子受容体を利用し
ない。
活性発現に還元型グルタチオンの添加を要しな
い。
(2) 基質特異性
ホルムアルデヒドの他にアセトアルデヒド、プ
ロピオンアルデヒド、メチルグリオキザル、グリ
オキザルにも作用するが、炭素数4以上のアルデ
ヒド類、アルコール類としてメタノール、エタノ
ール、プロパノール、エチレングリコール、グリ
セロール、脂肪酸およびアミン類には作用しない
(基質濃度50mM)。
下記第表に本発明の新規なホルムアルデヒド
デヒドロゲナーゼの各種基質に対する相対活性を
示す。
The present invention relates to a novel formaldehyde dehydrogenase and a method for producing the same. Formaldehyde dehydrogenase, which has been known for a long time, is produced by yeast and bovine liver.
NAD) produces enzymatic action only in the presence of reduced glutathione (Enzyme Handbook,
(Refer to Asakura Shoten, p. 97, 1977). Also, although the addition of NAD and/or reduced glutatin is not required, dichlorophenol indophenol (hereinafter referred to as
Formaldehyde dehydrogenase (Antonie van Leeuwenh
-ock Vol. 41, pp. 89-95, 1975), and furthermore
Formaldehyde dehydrogenase is known that does not require the addition of NAD or reduced glutathione, but requires the addition of pteridine or phenazine methosulfate, and also has an oxidizing effect on methanol. (Agr.Biol.Chem.Volume 41 No.
467, 1977). In addition, microorganisms belonging to the genus Pseudomonas are NAD.
It is known that it has the ability to produce formaldehyde dehydrogenase, which uses as an electron acceptor and does not require the addition of reduced glutathione to exhibit its activity (see Biochem. J., Vol. 116, pp. 357-365, 1970). The present inventors discovered that the mechanism of action is completely different from that of formaldehyde dehydrogenase, which acts on formaldehyde, acetaldehyde, propionaldehyde, methylglyoxal, and glyoxal using only NAD as an electron acceptor; We have discovered a novel formaldehyde dehydrogenase that does not act on methanol, ethanol, propanol, ethylene glycol, glycerol, fatty acids, and amino acids (substrate concentration 50mM), and does not require the addition of reduced glutathione to express its activity, and has achieved the present invention. Reached. That is, the present invention provides (1) at least the following properties ~
This is a novel formaldehyde dehydrogenase comprising the following. HCHO+NAD+ H2O →HCOOH+NADH 2As mentioned above, formaldehyde is oxidized to form formic acid via nicotinamide adenine dinucleotide, and it does not have the opposite effect. Nicotinamide adenine dinucleotide is the only electron acceptor. It does not utilize other electron acceptors such as nicotinamide adenine dinucleotide phosphate. Addition of reduced glutathione is not required for activity expression. Km value for formaldehyde is 8×10 -5 M
(PH7.5), and the Km value for NAD is 12×
10 -5 M (PH7.5). In addition to formaldehyde, acetaldehyde,
propionaldehyde, methylglyoxal,
Although it acts on glyoxal, it does not act on aldehydes with 4 or more carbon atoms, alcohols such as methanol, ethanol, propanol, ethylene glycol, glycerol, fatty acids, and amines (substrate concentration 50 mM). The molecular weight is 150000±1000 and the isoelectric point is PI=
5.2±0.1, and the optimum pH is 7.0 to 8.0. Stable against nonionic surfactants, but susceptible to anionic, cationic and amphoteric surfactants. The formaldehyde dehydrogenase of the present invention does not require the addition of reduced glutathione, and has the advantage that it does not require the addition of reduced glutathione.
(see p. 1977). In addition, conventional formaldehyde dehydrogenase (Antonie van Leeuwenh
(see ock Vol. 41, pp. 89-95, 1975). Furthermore, in that it does not have an oxidizing effect on methanol, conventional formaldehyde dehydrogenase (Agr. Biol. Chem. Vol. 41, p. 467)
1977), and methylamine,
Conventional formaldehyde dehydrogenase (Biochem.J.
116, pp. 357-865, 1970). Next, the novel formaldehyde dehydrogenase of the present invention will be described in detail. (1) Action As shown below, formaldehyde is oxidized to form formic acid via NAD, and it does not have the opposite action. HCHO + NAD + H 2 O → HCOOH + NADH 2 Utilizing only NAD as the electron acceptor, other substances such as nicotinamide adenine dinucleotide phosphate (NADP), dichlorophenol indophenol (DCPIP), pteridine, phenazine methosulfate (PMS) Does not utilize electron acceptors. Addition of reduced glutathione is not required for activity expression. (2) Substrate specificity In addition to formaldehyde, it also acts on acetaldehyde, propionaldehyde, methylglyoxal, and glyoxal, but aldehydes with 4 or more carbon atoms, alcohols such as methanol, ethanol, propanol, ethylene glycol, glycerol, fatty acids, It does not act on amines (substrate concentration 50mM). The table below shows the relative activity of the novel formaldehyde dehydrogenase of the present invention against various substrates.
【表】
(3) 至適PHおよび安定PH範囲
本発明の酵素のPH作用曲線を第1図に、25℃、
16時間におけるPH安定曲線を第2図に示す。
至適PHはPH7.5付近であり、安定PH範囲は25
℃、16時間処理においてPH8.5〜9.5である。
(4) 力価の測定法
(i) NADの還元における340nmの吸収増加法
10mMのホルムアルデヒド溶液(PH7.5)1
mlと10mMのNAD溶液0.5mlを1cm巾の石英セ
ルに添加し、37℃で予備加温しておく。適当に
希釈した酵素液0.5mlを添加して直ちに分光光
度計で340nmにおける吸光度を記録し、その直
線部分から1分間の吸光度変化を読み取り、次
式により酵素活性を計算する。
U/ml=△E340×2.0(ml)/6.22×0
.5(ml)
(ii) ジホルマザン法
0.5%のトリトンX―100を含む10mMホルム
アルデヒド溶液(PH7.5)0.5ml、0.01%PMSと
0.1%のNTBを含む溶液0.1ml、3mMのNADを
含む水溶液0.1mlを混合し、37℃に予備加温す
る。酵素液0.5mlを注加して酵素反応せしめ、
15分後、0.3NHCl、3mlで反応を停止させ、
570nmにおける吸光度を読む。0.3NHClを添加
してから酵素液を添加した場合を対照として次
式により酵素活性を計算する。
U/ml=△E570×4.2ml/20.1×15×
0.5
いずれの場合も酵素作用及び発色変化は次式に
従つており、両者における酵素活性表示値は一致
する。尚1単位は37℃、PH7.5において1分間に
1マイクロモルのホルムアルデヒドを分解する量
と定義する。
(5) 作用温度の範囲
本発明の酵素の温度活性曲線を第3図に、PH
7.5、30分間処理における温度安定曲線を第4図
に示す。作用適温は約40℃付近であり、PH7.5、
30分間処理において40℃まで安定である。
(6) 各種金属および界面活性剤による影響
Ni〓Zn〓Mn〓Hg〓Cd〓により酵素は阻害さ
れるが、その他の金属では影響を受けない。又非
イオン系界面活性剤には影響を受けないが、アニ
オン系及びカチオン系界面活性剤で阻害される。[Table] (3) Optimal PH and stable PH range The PH action curve of the enzyme of the present invention is shown in Figure 1.
Figure 2 shows the PH stability curve for 16 hours. Optimal PH is around PH7.5, stable PH range is 25
℃, pH 8.5-9.5 after 16 hours treatment. (4) Potency measurement method (i) 340nm absorption increase method in NAD reduction 10mM formaldehyde solution (PH7.5) 1
ml and 0.5 ml of 10 mM NAD solution are added to a 1 cm wide quartz cell and prewarmed at 37°C. Immediately after adding 0.5 ml of an appropriately diluted enzyme solution, record the absorbance at 340 nm using a spectrophotometer, read the change in absorbance over 1 minute from the linear portion, and calculate the enzyme activity using the following formula. U/ml=△E340×2.0(ml)/6.22×0
.. 5 (ml) (ii) Diformazan method 0.5ml of 10mM formaldehyde solution (PH7.5) containing 0.5% Triton X-100, 0.01% PMS and
Mix 0.1 ml of a solution containing 0.1% NTB and 0.1 ml of an aqueous solution containing 3 mM NAD and prewarm to 37 °C. Pour 0.5ml of enzyme solution to allow enzyme reaction.
After 15 minutes, the reaction was stopped with 3 ml of 0.3NHCl.
Read the absorbance at 570nm. Using the case where 0.3NHCl is added and then the enzyme solution is added as a control, the enzyme activity is calculated using the following formula. U/ml=△E570×4.2ml/20.1×15×
0.5 In either case, the enzyme action and color change follow the following formula, and the enzyme activity display values in both cases match. One unit is defined as the amount that decomposes 1 micromole of formaldehyde per minute at 37°C and pH 7.5. (5) Range of action temperature The temperature activity curve of the enzyme of the present invention is shown in Figure 3.
7.5, the temperature stability curve for 30 minutes treatment is shown in Figure 4. The suitable temperature for action is around 40℃, PH7.5,
Stable up to 40°C for 30 minutes. (6) Effects of various metals and surfactants The enzyme is inhibited by Ni〓Zn〓Mn〓Hg〓Cd〓, but is not affected by other metals. It is not affected by nonionic surfactants, but is inhibited by anionic and cationic surfactants.
【表】
(7) 分子量
セフアデツクスG―200によるゲル過法で
150000±1000であり、SDSポリアクリルアミドを
用いたDISC電気泳動法では72000±2000である。
(8) 等電点
アンホライン電気泳動法でPI=5.2±0.1であ
る。
(9) Km値
ラインウエーバーバーク・プロツトからホルム
アルデヒドに対して8×10-5M(PH7.5)、NADに
対して12×10-5M(PH7.5)である。又その作用
図からピンポンBiBiメカニズムによる反応である
と推定される。
本発明の酵素は微生物の培養により生産される
が、微生物としてはシユードモナス属、アクロモ
バクター属、アースロバクター属、プロテウス
属、セラチア属、アグロバクテリウム属、エツシ
エリヒア属またはミクロコツカス属などがその生
産能を有する。特にシユードモナス属の微生物が
望ましい。
次に本発明の酵素の製造法について述べる。
本発明で使用する培地は炭素源、窒素源、無機
物、その他の栄養素を程良く含有する培地ならば
合成培地または天然培地のいずれも使用可能であ
る。特に液体培地が好ましい。
炭素源としてはグルコース、フルクトース、シ
ユクロース、マルトース、マンノース、澱粉、澱
粉加水分解液、糖密などの種々の炭水化物あるい
はグリセロール、ソルビトール、マンニトールな
どの種々の糖アルコールが使用でき、また酢酸、
乳酸、ピルビン酸、フマール酸、クエン酸などの
各種有機酸、メタノール、エタノールなどの各種
アルコール、エチレングリコール、プロピレング
リコールなどの各種グリコール、各種アミノ酸、
あるいはn―ヘキサデカンなどの炭化水素も使用
可能である。
窒素源としてはアンモニアあるいは塩化アンモ
ニウム、炭酸アンモニウム、燐酸アンモニウム、
硝酸アンモニウム、酢酸アンモニウムなどの各種
無機および有機アンモニウム塩、あるいは尿素、
アミノ酸およびその他の窒素化合物ならびにペプ
トン、NZ―アミン、肉エキス、コーンステープ
リカー、カゼイン加水分解物、蛹加水分解物、フ
イツシユミールあるいはその消化物、脱脂大豆あ
るいはその消化物などの窒素性有機物質などが使
用できる。
無機物としては燐酸第一カリウム、燐酸第二カ
リウム、塩化カリウム、硫酸マグネシウム、硫酸
マンガン、硫酸第一鉄、塩化ナトリウム、炭酸カ
ルシウムなどが使用できる。
その他の栄養素としては酵母エキスあるいは麦
芽エキスなどが好ましい。
本発明で使用する培地には酵素の誘導物質とし
て、ザルコシン、ベタイン、ジメチルグリシン、
コリン、ベタインアルデヒド、クレアチン、クレ
アチニン、メチルアミン、ジメチルアミン、トリ
メチルアミン、ホルムアルデヒド等の代謝前駆物
質またはこれらの混合物、これを含有する物質を
添加すれば、より多量のホルムアルデヒドデヒド
ロゲナーゼを生成させることができる。前記代謝
前駆物質の添加量は培地に対して0.05〜1.0重量
%であることが好ましい。ホルムアルデヒドは培
養終期に培地に極く微量添加すると酵素の生産性
は増大する。
培養温度は通常15〜40℃の範囲で、好適には28
〜33℃である。培養時のPHは通常6.0〜8.5範囲
で、好適には6.5〜8.5である。このような条件下
で1〜2日間培養すれば培養液および/または菌
体中にホルムアルデヒドデヒドロゲナーゼが多量
に生成する。
菌体は凍結融解、超音波破砕、ガラスビーズ磨
砕、機械的圧縮、自己消化など公知の方法で破砕
して菌体抽出物とする。
培養液および上記菌体抽出物からの酵素の抽出
は硫安塩析、脱塩、イオン交換クロマトグラフイ
ーに処して行なう。
本発明の新規なホルムアルデヒドデヒドロゲナ
ーゼは工業的な利用においてもその有意性が高
い。たとえば血液中の尿酸からウリカーゼの作用
で過酸化水素を生成せしめ、メタノールの存在下
でカタラーゼによりホルムアルデヒドに転換し、
ホルムアルデヒドデヒドロゲナーゼを利用してホ
ルムアルデヒドを測定する場合、
(i) 従来の酵素では還元型グルタチオンが定量に
妨害となるが、本発明の酵素では還元型グルタ
チオンの影響を受けない。
(ii) 上記ホルムアルデヒドの測定においてメタノ
ールに作用する酵素は利用できないが、本発明
の酵素はメタノールに作用しないから有用であ
る。
(iii) DCPIPを電子受容体として測定する場合、
DCPIPは酸化状態で着色している為にその添
加量に制限があるが、本発明の酵素はDCPIP
を電子受容体としないので、添加量に制限がな
い。
以下、実施例により微生物菌体からの具体的な
酵素の製造法及び得られた酵素の電子受容体、補
酵素に対する作用を説明する。
実施例 1
ベタイン1%、ポリペプトン1%、酵母エキス
0.4%、麦芽エキス0.1%、塩化アンモニウム0.2
%、リン酸第二カリウム1.4%、リン酸第一カリ
ウム0.3%となるように水道水に各種栄養源を溶
解した培地500mlを2容量の肩付フラスコへ入
れ、120℃で15分間殺菌した。シユードモナスエ
アルギノサ(Pseudomonas aeruginosa)IFO
3445を予め、同一培地で増殖させ、この種菌液10
mlを上記培地に植菌し、30℃で144r.p.m.の速度
で振とう培養し、40時間後遠心分離により菌体を
集めた。50mMリン酸緩衝液(PH7.5)100mlに上
記菌体を懸濁し、再び遠心分離した後、洗浄し、
この菌体を同一緩衝液50mlに懸濁した。この懸濁
液を超音波破砕装置で10分間破砕処理し、遠心分
離により粗酵素液を得た。次いで硫安を50%飽和
まで添加し、生じた沈殿物を遠心分離で集め、
25mMリン酸緩衝液にて再溶解した後、同一緩衝
液を外液として透析脱塩した。得られた液を予め
25mMリン酸緩衝液で平衝化したDEAE―セルロ
ースのカラムに負荷して吸着させた。同濃度の緩
衝液で良く洗つた後、0.3Mの塩化カリウムを含
むリン酸緩衝液を流すことにより粗製酵素が溶出
されて来た。溶出液にはホルムアルデヒドデヒド
ロゲナーゼは110単位含まれ、蛋白質は44mgであ
つた。
実施例 2
実施例1で得られた溶出液を脱塩し、得られた
溶液1ml(0.03単位/ml)に、10mMのホルムア
ルデヒド溶液1ml、3mMのNADおよび50mMの
リン酸緩衝液0.2ml添加し、37℃で反応させた。
NADの添加直後から340nmにおける吸光度の変
化を測定した。1分間当りの吸光度の増加は0.07
であつた。
同様にして、基質、補酵素および還元型グルタ
チオンを下記第1表に示されるように添加して吸
光度の変化を測定した。[Table] (7) Molecular weight by gel filtration method using Sephadex G-200
150000±1000, and 72000±2000 by DISC electrophoresis using SDS polyacrylamide. (8) Isoelectric point PI=5.2±0.1 by ampholine electrophoresis. (9) Km value From the Lineweber-Burk plot, it is 8×10 -5 M (PH7.5) for formaldehyde and 12×10 -5 M (PH7.5) for NAD. Also, from the action diagram, it is estimated that the reaction is due to the ping-pong BiBi mechanism. The enzyme of the present invention is produced by culturing microorganisms, and microorganisms such as Pseudomonas, Achromobacter, Arthrobacter, Proteus, Serratia, Agrobacterium, Ethscherichia, or Micrococcoccus are used to produce the enzyme. have the ability. Microorganisms of the genus Pseudomonas are particularly desirable. Next, the method for producing the enzyme of the present invention will be described. The medium used in the present invention may be either a synthetic medium or a natural medium as long as it contains adequate amounts of carbon sources, nitrogen sources, inorganic substances, and other nutrients. Particularly preferred is a liquid medium. As carbon sources, various carbohydrates such as glucose, fructose, sucrose, maltose, mannose, starch, starch hydrolyzate, and molasses, or various sugar alcohols such as glycerol, sorbitol, and mannitol can be used, and acetic acid,
Various organic acids such as lactic acid, pyruvic acid, fumaric acid, and citric acid, various alcohols such as methanol and ethanol, various glycols such as ethylene glycol and propylene glycol, various amino acids,
Alternatively, hydrocarbons such as n-hexadecane can also be used. Nitrogen sources include ammonia, ammonium chloride, ammonium carbonate, ammonium phosphate,
Various inorganic and organic ammonium salts such as ammonium nitrate, ammonium acetate, or urea,
Amino acids and other nitrogenous compounds, as well as nitrogenous organic substances such as peptone, NZ-amine, meat extract, corn staple liquor, casein hydrolyzate, pupa hydrolyzate, fruit meal or its digested product, defatted soybean or its digested product, etc. Can be used. Examples of inorganic substances that can be used include primary potassium phosphate, secondary potassium phosphate, potassium chloride, magnesium sulfate, manganese sulfate, ferrous sulfate, sodium chloride, and calcium carbonate. As other nutrients, yeast extract or malt extract is preferable. The medium used in the present invention contains sarcosine, betaine, dimethylglycine,
A larger amount of formaldehyde dehydrogenase can be produced by adding metabolic precursors such as choline, betaine aldehyde, creatine, creatinine, methylamine, dimethylamine, trimethylamine, formaldehyde, or mixtures thereof, or substances containing these. The amount of the metabolic precursor added is preferably 0.05 to 1.0% by weight based on the medium. When a very small amount of formaldehyde is added to the medium at the final stage of culture, enzyme productivity increases. The culture temperature is usually in the range of 15-40℃, preferably 28℃.
~33℃. The pH during culture is usually in the range of 6.0 to 8.5, preferably 6.5 to 8.5. If cultured under such conditions for 1 to 2 days, a large amount of formaldehyde dehydrogenase will be produced in the culture solution and/or the bacterial cells. The bacterial cells are crushed to obtain a bacterial cell extract by a known method such as freezing and thawing, ultrasonic crushing, glass bead grinding, mechanical compression, and autolysis. The enzyme is extracted from the culture solution and the above bacterial cell extract by salting out ammonium sulfate, desalting, and ion exchange chromatography. The novel formaldehyde dehydrogenase of the present invention is also highly significant in industrial applications. For example, hydrogen peroxide is generated from uric acid in the blood by the action of uricase, which is converted to formaldehyde by catalase in the presence of methanol.
When formaldehyde is measured using formaldehyde dehydrogenase, (i) reduced glutathione interferes with quantitative determination using conventional enzymes, but the enzyme of the present invention is not affected by reduced glutathione. (ii) Although enzymes that act on methanol cannot be used in the measurement of formaldehyde, the enzyme of the present invention is useful because it does not act on methanol. (iii) When measuring DCPIP as an electron acceptor,
DCPIP is colored in its oxidized state, so there is a limit to the amount that can be added, but the enzyme of the present invention
Since it does not act as an electron acceptor, there is no limit to the amount added. Hereinafter, a specific method for producing enzymes from microbial cells and the effects of the obtained enzymes on electron acceptors and coenzymes will be explained with reference to Examples. Example 1 Betaine 1%, polypeptone 1%, yeast extract
0.4%, malt extract 0.1%, ammonium chloride 0.2
%, dibasic potassium phosphate 1.4%, and primary potassium phosphate 0.3%. 500 ml of a culture medium prepared by dissolving various nutrient sources in tap water was placed in a 2-capacity shoulder flask and sterilized at 120° C. for 15 minutes. Pseudomonas aeruginosa IFO
3445 was grown in the same medium in advance, and this inoculum solution 10
ml was inoculated into the above medium, cultured with shaking at 30° C. at a speed of 144 rpm, and after 40 hours, the bacterial cells were collected by centrifugation. Suspend the above bacteria in 100ml of 50mM phosphate buffer (PH7.5), centrifuge again, and wash.
The cells were suspended in 50 ml of the same buffer. This suspension was crushed using an ultrasonic crusher for 10 minutes, and then centrifuged to obtain a crude enzyme solution. Ammonium sulfate was then added to 50% saturation, and the resulting precipitate was collected by centrifugation.
After redissolving in 25mM phosphate buffer, dialysis and desalting were performed using the same buffer as an external solution. Pour the obtained liquid in advance
It was loaded and adsorbed onto a DEAE-cellulose column equilibrated with 25mM phosphate buffer. After thorough washing with a buffer solution of the same concentration, the crude enzyme was eluted by flowing a phosphate buffer solution containing 0.3M potassium chloride. The eluate contained 110 units of formaldehyde dehydrogenase and 44 mg of protein. Example 2 The eluate obtained in Example 1 was desalted, and to 1 ml of the obtained solution (0.03 units/ml) was added 1 ml of 10 mM formaldehyde solution, 3 mM NAD, and 0.2 ml of 50 mM phosphate buffer. , reacted at 37°C.
Immediately after the addition of NAD, changes in absorbance at 340 nm were measured. Increase in absorbance per minute is 0.07
It was hot. Similarly, substrates, coenzymes, and reduced glutathione were added as shown in Table 1 below, and changes in absorbance were measured.
【表】
第1表から明らかなように本発明の酵素は還元
型グルタチオンの添加を要せず、また蟻酸には作
用しないことが明らかである。
また、実施例1で得られた溶出液を脱塩し、得
られた溶液に5mMのホルムアルデヒド溶液を等
量混合し、予め37℃に加温した。この混合液2ml
に次の電子受容体を0.2ml添加し、各々の特異吸
収体での吸光度変化を測定した。その結果を第2
表に示す。[Table] As is clear from Table 1, the enzyme of the present invention does not require the addition of reduced glutathione, and it is clear that it does not act on formic acid. Further, the eluate obtained in Example 1 was desalted, and an equal amount of 5 mM formaldehyde solution was mixed with the obtained solution, and the mixture was heated to 37° C. in advance. 2ml of this mixture
0.2 ml of the following electron acceptors were added to the solution, and the change in absorbance for each specific absorber was measured. The result is the second
Shown in the table.
【表】
第2表から明らかなように本発明の酵素は電子
受容体としてNADのみを利用する。
さらに実施例1で得られた溶出液を脱塩し、得
られた溶液を用い、セフアデツクスG―200によ
るゲル過法でホルムアルデヒドデヒドロゲナー
ゼの分子量を測定したところ、150000±1000であ
り、アンホライン電気泳動法によりホルムアルデ
ヒドデヒドロゲナーゼの等電点を測定したとこ
ろ、PI=5.2±0.1であつた。
また実施例1で得られたホルムアルデヒドデヒ
ドロゲナーゼのPH作用曲線および25℃,16時間に
おけるPH安定曲線を第1図および第2図に示す。
さらに温度活性曲線を第3図に、PH7.5,30分
間処理における温度安定線を第4図に示す。
実施例1で得られたホルムアルデヒドデヒドロ
ゲナーゼのKm値をラインウエーバーバーク・プロ
ツトから測定したところ、ホルムアルデヒドに対
して8×10-5M(PH7.5)、NADに対して12×
10-5M(PH7.5)であつた。
実施例1で得られたホルムアルデヒドデヒドロ
ゲナーゼの各種基質に対する相対活性を前記第1
表に示し、各種金属および界面活性剤による影響
を前記表に示す。[Table] As is clear from Table 2, the enzyme of the present invention uses only NAD as an electron acceptor. Furthermore, the eluate obtained in Example 1 was desalted, and the molecular weight of formaldehyde dehydrogenase was measured using the gel filtration method using Sephadex G-200 using the obtained solution. The isoelectric point of formaldehyde dehydrogenase was measured using PI=5.2±0.1. Further, the PH action curve and PH stability curve at 25° C. for 16 hours of formaldehyde dehydrogenase obtained in Example 1 are shown in FIGS. 1 and 2. Furthermore, the temperature activity curve is shown in Fig. 3, and the temperature stability line after treatment at pH 7.5 for 30 minutes is shown in Fig. 4. When the Km value of formaldehyde dehydrogenase obtained in Example 1 was measured from a Lineweber-Burk plot, it was found to be 8×10 -5 M (PH7.5) for formaldehyde and 12× for NAD.
It was 10 -5 M (PH7.5). The relative activity of formaldehyde dehydrogenase obtained in Example 1 against various substrates was determined using the first
The effects of various metals and surfactants are shown in the table above.
第1図は本発明の酵素のPH作用曲線を示す。第
2図は本発明の酵素のPH安定曲線を示す。第3図
は本発明の酵素の温度活性曲線を示す。第4図は
本発明の酵素の温度安定曲線を示す。
FIG. 1 shows the PH action curve of the enzyme of the invention. FIG. 2 shows the PH stability curve of the enzyme of the invention. FIG. 3 shows the temperature activity curve of the enzyme of the invention. FIG. 4 shows the temperature stability curve of the enzyme of the invention.
Claims (1)
なホルムアルデヒドデヒドロゲナーゼ。 HCHO+NAD+H2O→HCOOH+NADH2 上記のごとく、ニコチンアミドアデニンジヌ
クレオチドを介してホルムアルデヒドを酸化し
て蟻酸を生成し、逆の作用を有しない。 ニコチンアミドアデニンジヌクレオチドのみ
を電子受容体とする。 活性発現に還元型グルタチオンの添加を要し
ない。 ホルムアルデヒドに対するKm値が8×10-5M
(PH7.5)であり、NADに対するKm値が12×
10-5M(PH7.5)である。 ホルムアルデヒドの他にアセトアルデヒド、
プロピオンアルデヒド、メチルグリオキザル、
グリオキザルにも作用するが、炭素数4以上の
アルデヒド類、アルコール類としてメタノー
ル、エタノール、プロパノール、エチレングリ
コール、グリセロール、脂肪酸およびアミン類
には作用しない。(基質濃度50mM) 分子量(セフアデツクスG―200によるゲル
濾過法)が15000±1000であり、等電点がPI=
5.2±0.1であり、至適PHが7.0〜8.0である。 非イオン系界面活性剤に対して安定である
が、アニオン系、カチオン系及び両性界面活性
剤に対して不安定である。[Scope of Claims] 1. A novel formaldehyde dehydrogenase having at least the following properties. HCHO+NAD+ H2O →HCOOH+NADH 2As mentioned above, formaldehyde is oxidized to form formic acid via nicotinamide adenine dinucleotide, and it does not have the opposite effect. Nicotinamide adenine dinucleotide is the only electron acceptor. Addition of reduced glutathione is not required for activity expression. Km value for formaldehyde is 8×10 -5 M
(PH7.5), and the Km value for NAD is 12×
10 -5 M (PH7.5). In addition to formaldehyde, acetaldehyde,
propionaldehyde, methylglyoxal,
Although it acts on glyoxal, it does not act on aldehydes with 4 or more carbon atoms, alcohols such as methanol, ethanol, propanol, ethylene glycol, glycerol, fatty acids, and amines. (Substrate concentration 50mM) The molecular weight (gel filtration method using Cephadex G-200) is 15000±1000, and the isoelectric point is PI=
5.2±0.1, and the optimum pH is 7.0 to 8.0. It is stable to nonionic surfactants, but unstable to anionic, cationic, and amphoteric surfactants.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12656878A JPS5554894A (en) | 1978-10-13 | 1978-10-13 | Novel formaldehyde-dehydrogenase and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12656878A JPS5554894A (en) | 1978-10-13 | 1978-10-13 | Novel formaldehyde-dehydrogenase and its preparation |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6740579A Division JPS5552944A (en) | 1979-05-30 | 1979-05-30 | Novel quantitizing method of formaldehyde with formaldehyde dehydrogenase |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5554894A JPS5554894A (en) | 1980-04-22 |
JPS6155946B2 true JPS6155946B2 (en) | 1986-11-29 |
Family
ID=14938376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12656878A Granted JPS5554894A (en) | 1978-10-13 | 1978-10-13 | Novel formaldehyde-dehydrogenase and its preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5554894A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60186297A (en) * | 1984-03-06 | 1985-09-21 | Oriental Yeast Co Ltd | Removal of nad+ activation inhibitor |
-
1978
- 1978-10-13 JP JP12656878A patent/JPS5554894A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5554894A (en) | 1980-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH031949B2 (en) | ||
JP3590647B2 (en) | Alcohol / aldehyde dehydrogenase | |
US4266023A (en) | Glycerol oxidase and process for the production thereof and method for the quantitative determination of glycerol by glycerol oxidase | |
EP0012446B1 (en) | Acidic uricase, its production and its use for the determination of uric acid | |
US4770997A (en) | Thermostable bilirubin oxidase and production process thereof | |
US4011138A (en) | Process for the preparation of cholesterol esterase | |
JPS59198972A (en) | Microbiologically produced l-phenylalanine dehydrogenase, obtaining method thereof and production of l-alpha-amino- carboxylic acid | |
Hou et al. | Substrate specificity and stereospecificity of nicotinamide adenine dinucleotide-linked alcohol dehydrogenases from methanol-grown yeasts | |
US4245050A (en) | Process for the preparation of choline oxidase by fermentation | |
JPH0134035B2 (en) | ||
JPS6155946B2 (en) | ||
US4954445A (en) | Novel NAD(P)H oxidase | |
Pritchard | An NAD+-independent L-lactate dehydrogenase from Rhizopus oryzae | |
US4255519A (en) | Glycerol oxidase and process for the production thereof | |
EP0790301B1 (en) | Aldehyde Dehydrogenase | |
JPS6342519B2 (en) | ||
JP2726826B2 (en) | Enzyme and method for producing the same | |
US4335213A (en) | Process for the preparation of galactose oxidase | |
JPS6243670B2 (en) | ||
US4550079A (en) | Determination of L(+)-tartrate or D(+)-malate with L(+)-tartrate dehydrogenase | |
Snoswell | [58] dl-Lactate dehydrogenases (NAD+-independent) from Lactobacillus arabinosus | |
JP4051579B2 (en) | Novel glycerol kinase and process for producing the same | |
JP3490184B2 (en) | Novel N-alkylglycine oxidase, method for producing the same, reagent for quantifying Nε-carboxymethyllysine using the enzyme, and method for quantifying the same | |
JPS63251082A (en) | Production of nadh oxidase | |
JP3156832B2 (en) | Ammonia measurement reagent composition |